Impact of Prescription Quality, Infection Control and Antimicrobial Stewardship on Gut Microbiota Domination by Healthcare-Associated Pathogens (PILGRIM)
Sponsor: Goethe University
This observational or N/A phase trial investigates Patients at High Risk of Antibacterial Treatment Upon Admission and is currently ongoing. Goethe University leads this study, which shows 11 recorded versions since 2019 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Mar 2023 — Jul 2024 [monthly]
Unknown Status
-
Nov 2022 — Mar 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Apr 2022 — Nov 2022 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Sep 2020 [monthly]
Not Yet Recruiting
-
Jan 2019 — Oct 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Goethe University
- Haukeland University Hospital
- Helse Stavanger HF
- Karolinska Institutet
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Rabin Medical Center
- University Hospital of Cologne
- University Hospital of North Norway
- University Hospital, Akershus
- University of Latvia
For direct contact, visit the study record on ClinicalTrials.gov .